Development and Validation of a Real-Time PCR Assay for Rapid Detection of Candida auris from Surveillance Samples
- PMID: 29187562
- PMCID: PMC5786737
- DOI: 10.1128/JCM.01223-17
Development and Validation of a Real-Time PCR Assay for Rapid Detection of Candida auris from Surveillance Samples
Abstract
Candida auris is an emerging multidrug-resistant yeast causing invasive health care-associated infection with high mortality worldwide. Rapid identification of C. auris is of primary importance for the implementation of public health measures to control the spread of infection. To achieve these goals, we developed and validated a TaqMan-based real-time PCR assay targeting the internal transcribed spacer 2 (ITS2) region of the ribosomal gene. The assay was highly specific, reproducible, and sensitive, with the detection limit of 1 C. auris CFU/PCR. The performance of the C. auris real-time PCR assay was evaluated by using 623 surveillance samples, including 365 patient swabs and 258 environmental sponges. Real-time PCR yielded positive results from 49 swab and 58 sponge samples, with 89% and 100% clinical sensitivity with regard to their respective culture-positive results. The real-time PCR also detected C. auris DNA from 1% and 12% of swab and sponge samples with culture-negative results, indicating the presence of dead or culture-impaired C. auris The real-time PCR yielded results within 4 h of sample processing, compared to 4 to 14 days for culture, reducing turnaround time significantly. The new real-time PCR assay allows for accurate and rapid screening of C. auris and can increase effective control and prevention of this emerging multidrug-resistant fungal pathogen in health care facilities.
Keywords: Candida auris; TaqMan chemistry; assay validation; real-time PCR assay; surveillance samples.
Copyright © 2018 Leach et al.
Figures
Similar articles
-
Validation and implementation of a commercial real-time PCR assay for direct detection of Candida auris from surveillance samples.Mycoses. 2021 Jun;64(6):612-615. doi: 10.1111/myc.13250. Epub 2021 Feb 9. Mycoses. 2021. PMID: 33529398
-
A TaqMan Probe-Based Real-Time PCR Assay for the Rapid Identification of the Emerging Multidrug-Resistant Pathogen Candida auris on the BD Max System.J Clin Microbiol. 2019 Jun 25;57(7):e01604-18. doi: 10.1128/JCM.01604-18. Print 2019 Jul. J Clin Microbiol. 2019. PMID: 31068411 Free PMC article.
-
A high-throughput and rapid method for accurate identification of emerging multidrug-resistant Candida auris.Mycoses. 2019 Jun;62(6):513-518. doi: 10.1111/myc.12907. Epub 2019 Apr 4. Mycoses. 2019. PMID: 30801778 Free PMC article.
-
Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases.Intern Med J. 2019 Oct;49(10):1229-1243. doi: 10.1111/imj.14612. Intern Med J. 2019. PMID: 31424595 Review.
-
Approach to the Investigation and Management of Patients With Candida auris, an Emerging Multidrug-Resistant Yeast.Clin Infect Dis. 2018 Jan 6;66(2):306-311. doi: 10.1093/cid/cix744. Clin Infect Dis. 2018. PMID: 29020224 Free PMC article. Review.
Cited by
-
Enhancing ICU Candida spp. surveillance: a cost-effective approach focused on Candida auris detection.Front Cell Infect Microbiol. 2024 Nov 1;14:1463456. doi: 10.3389/fcimb.2024.1463456. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39554808 Free PMC article.
-
The Candida auris Infection After the COVID-19 Pandemic Seems to be an Urgent Public Health Emergency: A Call to Attention.Health Sci Rep. 2024 Oct 29;7(11):e70160. doi: 10.1002/hsr2.70160. eCollection 2024 Nov. Health Sci Rep. 2024. PMID: 39474347 Free PMC article.
-
Early Introductions of Candida auris Detected by Wastewater Surveillance, Utah, USA, 2022-2023.Emerg Infect Dis. 2024 Oct;30(10):2107-2117. doi: 10.3201/eid3010.240173. Emerg Infect Dis. 2024. PMID: 39320163 Free PMC article.
-
Development of a TaqMan probe-based multiplex real-time PCR for the simultaneous detection of four clinically important filamentous fungi.Microbiol Spectr. 2024 Sep 3;12(9):e0063424. doi: 10.1128/spectrum.00634-24. Epub 2024 Jul 30. Microbiol Spectr. 2024. PMID: 39078160 Free PMC article.
-
A simple and sensitive test for Candida auris colonization, surveillance, and infection control suitable for near patient use.J Clin Microbiol. 2024 Jul 16;62(7):e0052524. doi: 10.1128/jcm.00525-24. Epub 2024 Jun 18. J Clin Microbiol. 2024. PMID: 38888304
References
-
- Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP. 2017. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64:134–140. doi:10.1093/cid/ciw691. - DOI - PMC - PubMed
-
- Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, Kemble SK, Pacilli M, Black SR, Landon E, Ridgway J, Palmore TN, Zelzany A, Adams EH, Quinn M, Chaturvedi S, Greenko J, Fernandez R, Southwick K, Furuya EY, Calfee DP, Hamula C, Patel G, Barrett P, Msd Lafaro P, Berkow EL, Moulton-Meissner H, Noble-Wang J, Fagan RP, Jackson BR, Lockhart SR, Litvintseva AP, Chiller TM. 2016. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus—United States, May 2013–August 2016. MMWR Morb Mortal Wkly Rep 65:1234–1237. doi:10.15585/mmwr.mm6544e1. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

